No menu items!

Uruguay approves drug that delays the effect of a type of lung cancer

RIO DE JANEIRO, BRAZIL - Each year some 1.8 million people die of lung cancer in the world. In Uruguay, over 1,300 die from the disease. Although prostate cancer is the most common form of cancer in the country, lung cancer kills the most. As for women, it is the third most common type of fatal cancer.

The rate is increasing dramatically: among women alone, the mortality rate
per year is growing by 3.6%.

Uruguay's Ministry of Public Health approved the use of the new drug developed by Pfizer. It has also been approved by countries such . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content